AT349150B - Verfahren zur herstellung pharmazeutischer pulver - Google Patents

Verfahren zur herstellung pharmazeutischer pulver

Info

Publication number
AT349150B
AT349150B AT31875A AT31875A AT349150B AT 349150 B AT349150 B AT 349150B AT 31875 A AT31875 A AT 31875A AT 31875 A AT31875 A AT 31875A AT 349150 B AT349150 B AT 349150B
Authority
AT
Austria
Prior art keywords
pharmaceutical powder
producing pharmaceutical
producing
powder
pharmaceutical
Prior art date
Application number
AT31875A
Other languages
German (de)
English (en)
Other versions
ATA31875A (de
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of ATA31875A publication Critical patent/ATA31875A/de
Application granted granted Critical
Publication of AT349150B publication Critical patent/AT349150B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT31875A 1974-01-18 1975-01-17 Verfahren zur herstellung pharmazeutischer pulver AT349150B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA00740385A ZA74385B (en) 1974-01-18 1974-01-18 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
ATA31875A ATA31875A (de) 1978-08-15
AT349150B true AT349150B (de) 1979-03-26

Family

ID=25567281

Family Applications (1)

Application Number Title Priority Date Filing Date
AT31875A AT349150B (de) 1974-01-18 1975-01-17 Verfahren zur herstellung pharmazeutischer pulver

Country Status (18)

Country Link
JP (1) JPS5837284B2 (ja)
AT (1) AT349150B (ja)
AU (1) AU485660B2 (ja)
BE (1) BE824509A (ja)
CA (1) CA1040532A (ja)
CH (1) CH622947A5 (ja)
DE (1) DE2501787A1 (ja)
DK (1) DK151770C (ja)
ES (1) ES433908A1 (ja)
FI (1) FI750113A (ja)
FR (1) FR2258177B1 (ja)
GB (1) GB1478742A (ja)
IE (1) IE40361B1 (ja)
IT (1) IT1036072B (ja)
LU (1) LU71668A1 (ja)
NL (1) NL185130C (ja)
SE (1) SE437930B (ja)
ZA (1) ZA74385B (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
PH20649A (en) * 1981-09-22 1987-03-16 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
US4801608A (en) * 1981-09-22 1989-01-31 Gist-Brocades N. V. Bismuth containing composition and method for the preparation thereof
AU590578B2 (en) * 1985-04-18 1989-11-09 Procter & Gamble Company, The Treatment of non-ulcer dyspepsia with bismuth salts
US4748113A (en) * 1985-06-13 1988-05-31 Marshall Barry J Compositions and methods for the diagnosis of gastrointestinal disorders involving urease
EP0206626B2 (en) * 1985-06-13 2002-05-22 Barry James Dr. Marshall Use of Bismuth for the manufacture of a medicament for the treatment of gastrointestinal disorders induced by Campylobacter polyridis
ATE318144T1 (de) * 1985-06-13 2006-03-15 Barry James Marshall Pharmazeutische zusammensetzung zur behandlung gastrointestinaler beschwerden, die wismut und ein antimikrobielles mittel enthält
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
EP0363502B1 (de) * 1988-10-08 1991-09-25 Dr. R. Pfleger Chemische Fabrik Gmbh Flüssiges, wismuthaltiges Arzneipräparat, Verfahren zum Herstellen desselben und seine Verwendung
DE3901508C2 (de) * 1989-01-19 1994-04-07 Falk Pharma Gmbh Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form
IT1229502B (it) * 1989-01-25 1991-09-03 Euroresearch Srl Composizioni contenenti bismuto idonee per uso terapeutico.
IE893167A1 (en) * 1989-10-04 1991-04-24 Ulso Lab Ltd Preparation of orally administrable liquids for use in¹therapy
ES2084174T3 (es) * 1990-07-20 1996-05-01 Tillotts Pharma Ag Productos y procesos para el tratamiento del conducto alimentario.
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
MX9703918A (es) 1997-05-28 1998-11-30 J Marshall M D Barry Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.
US7008777B2 (en) 2001-10-15 2006-03-07 Barry J. Marshall System for the detection of urease and method for using same
US6998250B2 (en) 2001-10-15 2006-02-14 Donald J. McMichael Method for detecting Helicobacter pylori
USD484988S1 (en) 2001-12-17 2004-01-06 Kimberly-Clark Worldwide, Inc. Diagnostic test kit with specimen-handling tool
US6783976B2 (en) 2001-12-21 2004-08-31 Kimberly-Clark Worldwide, Inc. Carrier and specimen-handling tool for use in diagnostic testing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963781A1 (de) * 1968-12-23 1970-07-09 Serfontein Willem Jacob Verbesserte Wismuth-Praeparate
GB1259151A (en) * 1968-12-23 1972-01-05 Willem Jacob Serfontein Bismuth complexes

Also Published As

Publication number Publication date
GB1478742A (en) 1977-07-06
AU7729375A (en) 1976-07-15
DK151770C (da) 1989-11-06
SE7500501L (ja) 1975-07-21
DK151770B (da) 1988-01-04
IT1036072B (it) 1979-10-30
IE40361B1 (en) 1979-05-09
FR2258177B1 (ja) 1978-07-21
NL185130C (nl) 1990-02-01
FR2258177A1 (ja) 1975-08-18
CA1040532A (en) 1978-10-17
LU71668A1 (ja) 1975-06-24
DE2501787A1 (de) 1975-07-24
DE2501787C2 (ja) 1987-11-12
AU485660B2 (en) 1977-07-28
SE437930B (sv) 1985-03-25
ZA74385B (en) 1975-08-27
CH622947A5 (en) 1981-05-15
JPS5837284B2 (ja) 1983-08-15
NL185130B (nl) 1989-09-01
NL7500552A (nl) 1975-07-22
IE40361L (en) 1975-07-18
JPS50116623A (ja) 1975-09-12
BE824509A (fr) 1975-07-17
ATA31875A (de) 1978-08-15
DK12675A (ja) 1975-09-15
ES433908A1 (es) 1976-11-16
FI750113A (ja) 1975-07-19

Similar Documents

Publication Publication Date Title
AT349150B (de) Verfahren zur herstellung pharmazeutischer pulver
AT352270B (de) Verfahren zur herstellung der neuen clavulansaeure
DD129644A5 (de) Verfahren zur herstellung neuer prostaglandinvorprodukte
AT366576B (de) Verfahren zur herstellung von pharmazeutischen praeparaten
AT355897B (de) Verfahren zur herstellung von schokolade- produkten
AT345654B (de) Futtermittel und verfahren zur herstellung desselben
AT344317B (de) Verfahren zur herstellung von arzneipraeparaten
DD122963A5 (de) Verfahren zur herstellung fluorierter verbindungen
AT342015B (de) Verfahren zur herstellung von acetoacetamid-n-sulfofluorid
AT356648B (de) Verfahren zur herstellung neuer indolderivate
AT344915B (de) Verfahren zur herstellung von tabletten
AT344136B (de) Verfahren zur herstellung von neuem 2-deutero-3-fluor-dl-alanin
DD132294A5 (de) Verfahren zur herstellung von tabakwaren
AT342191B (de) Verfahren zur herstellung von arzneimittelkombinationen
AT340546B (de) Verfahren zur herstellung von sauremassen
AT361630B (de) Verfahren zur herstellung von arzneimitteln
DD130933A5 (de) Verfahren zur herstellung von sulfinylazetidinonen
ATA924875A (de) Verfahren zur herstellung neuer 5-nitroimida- zolderivate
AT351523B (de) Verfahren zur herstellung von 2-alkyl-5- nitroimidazolderivaten
AT342205B (de) Verfahren zur herstellung von arzneimittelkugelchen
DD113583A2 (de) Verfahren zur herstellung raeumlicher baukoerper
AT387375B (de) Kontinuierliches verfahren zur herstellung von chlordioxid
AT374824B (de) Verfahren zur herstellung von reinigungsmittelpulvern
AT338974B (de) Verfahren zur herstellung von 7-amino-delta3-cephem-derivaten
AT340885B (de) Verfahren zur herstellung von acetoacetamid-n-sulfofluorid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EIH Change in the person of patent owner
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee